1252-Advancing Ovarian Cancer Care via Immunotherapy
This article examines the integration of targeted immunotherapies and magnetic nanoparticles (MNPs) to address the diagnostic and therapeutic hurdles of ovarian cancer. Traditional treatments often fail due to late-stage detection and high recurrence, but the synergy of nanomedicine with therapies like CAR-T cells and NK cells offers a more precise approach. MNPs enhance these treatments by serving as contrast agents for MRI, delivering drugs directly to tumors under magnetic guidance, and inducing hyperthermia to kill malignant cells. This interdisciplinary strategy aims to reverse the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.